Predict your next investment

CincyTech company logo
Venture Capital
BUSINESS PRODUCTS & SERVICES | Consulting & Outsourcing / Management & Strategy Consulting
cincytechusa.com

See what CB Insights has to offer

Investments

130

Portfolio Exits

14

Funds

10

Partners & Customers

2

About CincyTech

CincyTech is a public-private seed-stage investor whose mission is to strengthen the regional economy by driving talent and capital into scalable, investable technology companies in Southwest Ohio.

CincyTech Headquarter Location

2900 Reading Rd Suite 410

Cincinnati, Ohio, 45206,

United States

513-263-2720

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing CincyTech

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find CincyTech in 1 Expert Collection, including Fitness Tech.

F

Fitness Tech

227 items

We define fitness tech as companies leveraging software and technology to augment approaches to developing or maintaining physical fitness. Companies in this category develop tools and services including workout apps, wearables, and connected fitness equipment.

CincyTech Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

CincyTech Rank

Latest CincyTech News

07:04 EDT XII Medical completes $30 Million Series A Financing

May 5, 2022

News provided by Share this article World-class investor syndicate supports best-in-class, patient-centric solution for obstructive sleep apnea UNION CITY, Calif., May 5, 2022 /PRNewswire/ -- XII Medical, Inc., a private health technology company, today announced the closing of a $30 million Series A equity financing with a world-class syndicate of healthcare investors. Ajax Health led the financing, with co-lead Broadview Ventures and participation from founding investor Cleveland Clinic, as well as Aperture Venture Partners, JobsOhio Growth Capital Fund, CincyTech, and an undisclosed strategic investor. Funds will be utilized to advance the development of a proprietary, state-of-the-art, patient-centric solution for the millions of people suffering from obstructive sleep apnea. "We are thrilled to collaborate with an exceptional investor group with a track record of success, and we appreciate the considerable leverage we gain from their collective expertise, insight and resources," said Garrett Schwab, President and CEO of XII Medical. "This financing enables us to drive rapidly forward with our innovative approach to treating obstructive sleep apnea." XII Medical completes $30 million Series A financing for patient-centric solution for obstructive sleep apnea Obstructive sleep apnea (OSA) is a disorder in which the muscles in the throat temporarily relax, causing blockage of the airway during sleep. It is estimated that 425 million people, globally, have moderate to severe OSA requiring treatment.1 Current treatment options have poor compliance or require invasive surgery, leaving a significant number of patients untreated, undertreated and at risk of severe health complications. "As a physician, entrepreneur and investor with decades of experience advancing the standard of care for patients with airway disorders, I am excited by the potential for the thoughtfully designed XII Medical approach to become the preferred solution for patients for whom current OSA treatments are inadequate or intolerable," commented Anthony Natale, M.D., Managing Partner at Aperture Venture Partners and Executive Chairman of XII Medical. Duke Rohlen, Founder and CEO of Ajax Health stated, "The success of a company comes down to making the vector toward value creation as straight and focused as possible. This cannot be done without a core group of people who have tremendous experience and share a unified commitment to hard work. I believe the team and the technology at XII Medical are poised for excellence and I am proud to be part of this groundbreaking innovation." About XII Medical Founded in 2017 and headquartered in Union City, California, XII Medical, Inc. is a health technology company revolutionizing the treatment of obstructive sleep apnea. Privately held, the company is backed by Ajax Health, Cleveland Clinic, Aperture Venture Partners, Broadview Ventures, JobsOhio Growth Capital Fund, CincyTech, and an undisclosed strategic investor. Visit https://www.xiimedical.com/  for more information. About Ajax Health Ajax Health seeks to identify, invest in, and scale disruptive technologies in the healthcare space. Taking an active operating role, the Ajax team has a proven track record of helping companies of all sizes, stages, and structures achieve their value-creation goals. Ajax is headquartered in Menlo Park, CA. Benjafield, AV, Tayas NT, Eastwood PR, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019 Aug; 7(8): 687–698. SOURCE XII Medical, Inc.

CincyTech Investments

130 Investments

CincyTech has made 130 investments. Their latest investment was in XII Medical as part of their Series A on May 5, 2022.

CBI Logo

CincyTech Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/5/2022

Series A

XII Medical

$30M

Yes

5

5/2/2022

Seed VC

TeamCentral

$1.5M

Yes

2

1/27/2022

Series C

Enable Injections

$215M

No

10

6/10/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

6/1/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/5/2022

5/2/2022

1/27/2022

6/10/2021

6/1/2021

Round

Series A

Seed VC

Series C

Series A

Series B

Company

XII Medical

TeamCentral

Enable Injections

Subscribe to see more

Subscribe to see more

Amount

$30M

$1.5M

$215M

$99M

$99M

New?

Yes

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

5

2

10

10

10

CincyTech Portfolio Exits

14 Portfolio Exits

CincyTech has 14 portfolio exits. Their latest portfolio exit was Eccrine Systems on May 04, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

5/4/2022

Asset Sale

$99M

2

2/18/2022

IPO

$99M

Public

10

6/4/2020

Acquired

$99M

2

2/27/2019

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

6/1/2018

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/4/2022

2/18/2022

6/4/2020

2/27/2019

6/1/2018

Exit

Asset Sale

IPO

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

2

10

2

10

10

CincyTech Fund History

10 Fund Histories

CincyTech has 10 funds, including CincyTech Fund V.

Closing Date

Fund

Fund Type

Status

Amount

Sources

5/26/2021

CincyTech Fund V

$19.7M

4

6/25/2019

Cincinnati Cornerstone Investors BWV I

$4.64M

1

7/2/2018

Cincinnati Cornerstone Investors ES III

$0.8M

1

2/23/2017

Cincinnati Cornerstone Investors EI III

$99M

10

4/15/2016

CincyTech Fund IV

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

5/26/2021

6/25/2019

7/2/2018

2/23/2017

4/15/2016

Fund

CincyTech Fund V

Cincinnati Cornerstone Investors BWV I

Cincinnati Cornerstone Investors ES III

Cincinnati Cornerstone Investors EI III

CincyTech Fund IV

Fund Type

Subscribe to see more

Status

Subscribe to see more

Amount

$19.7M

$4.64M

$0.8M

$99M

$99M

Sources

4

1

1

10

10

CincyTech Partners & Customers

2 Partners and customers

CincyTech has 2 strategic partners and customers. CincyTech recently partnered with Link-age Ventures on March 3, 2012.

Date

Type

Business Partner

Country

News Snippet

Sources

3/20/2012

Partner

United States

CincyTech USA » Blog Archive » New Partnership With Linkage Ventures

Linkage Ventures and CincyTech have formed a unique strategic partnership to create and co-invest in startup companies whose technologies can help people as they age .

1

4/22/2010

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

3/20/2012

4/22/2010

Type

Partner

Partner

Business Partner

Country

United States

United States

News Snippet

CincyTech USA » Blog Archive » New Partnership With Linkage Ventures

Linkage Ventures and CincyTech have formed a unique strategic partnership to create and co-invest in startup companies whose technologies can help people as they age .

Subscribe to see more

Subscribe to see more

Sources

1

10

CincyTech Team

7 Team Members

CincyTech has 7 team members, including current Chief Executive Officer, Michael Venerable.

Name

Work History

Title

Status

Michael Venerable

Chief Executive Officer

Current

Stacey Browning

Paycor, and Groupe ADP

Managing Director

Current

Doug Groh

Managing Director

Current

John M. Rice

CS-Keys, and Senmed Medical Ventures

Managing Director

Current

Robert W Coy

Chief Executive Officer, President

Former

Name

Michael Venerable

Stacey Browning

Doug Groh

John M. Rice

Robert W Coy

Work History

Paycor, and Groupe ADP

CS-Keys, and Senmed Medical Ventures

Title

Chief Executive Officer

Managing Director

Managing Director

Managing Director

Chief Executive Officer, President

Status

Current

Current

Current

Current

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.